Effects of Metoprolol on Periprocedural Myocardial Infarction After Percutaneous Coronary Intervention (Type 4a MI): An Inverse Probability of Treatment Weighting Analysis

Background: Metoprolol is the most used cardiac selective β-blocker and has been recommended as a mainstay drug in the management of acute myocardial infarction (AMI). However, the evidence supporting this regimen in periprocedural myocardial infarction (PMI) is limited. Methods: This study identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Duanbin, Li, Ya, Lin, Maoning, Zhang, Wenjuan, Fu, Guosheng, Chen, Zhaoyang, Jin, Chongying, Zhang, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650586/
https://www.ncbi.nlm.nih.gov/pubmed/34888360
http://dx.doi.org/10.3389/fcvm.2021.746988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650586/
https://www.ncbi.nlm.nih.gov/pubmed/34888360
http://dx.doi.org/10.3389/fcvm.2021.746988

Ejemplares similares